Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Dogwood Therapeutics, Inc. (DWTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Dogwood Therapeutics, Inc. (DWTX), most recent 12 months reported: net loss $36.04M. Latest balance sheet on file: liquid cash $9.61M. From SEC filings. Others in Pharmaceutical Preparations: DiaMedica Therapeutics Inc. · DAMORA THERAPEUTICS, INC. · Dermata Therapeutics, Inc. · Design Therapeutics, Inc. · Dyne Therapeutics, Inc. · EDESA BIOTECH, INC. · Eledon Pharmaceuticals, Inc. · Elicio Therapeutics, Inc.

Stock screener

Watchlist